Ferenc Zádor
Ferenc Zádor
Research associate, Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University
E-mail megerősítve itt: pharma.semmelweis-univ.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity
F Zádor, D Kocsis, A Borsodi, S Benyhe
Neurochemistry international 67, 14-22, 2014
332014
Receptome: interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors
F Zádor, M Wollemann
Pharmacological research 102, 254-263, 2015
282015
Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Cav2.2 Blocker Multitarget Ligands
A Mollica, R Costante, E Novellino, A Stefanucci, S Pieretti, F Zador, ...
Chemical biology & drug design 86 (2), 156-162, 2015
282015
Novel cyclic biphalin analogue with improved antinociceptive properties
A Mollica, A Carotenuto, E Novellino, A Limatola, R Costante, F Pinnen, ...
ACS medicinal chemistry letters 5 (9), 1032-1036, 2014
222014
Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor …
F Zádor, N Lénárt, B Csibrány, M Sántha, M Molnár, B Tuka, R Samavati, ...
Neuropharmacology 89, 298-307, 2015
212015
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
A Mollica, S Pelliccia, V Famiglini, A Stefanucci, G Macedonio, ...
Journal of enzyme inhibition and medicinal chemistry 32 (1), 444-451, 2017
202017
A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy
E Lacko, A Varadi, R Rapavi, F Zador, P Riba, S Benyhe, A Borsodi, ...
Current medicinal chemistry 19 (27), 4699-4707, 2012
202012
Biochemistry of opioid (morphine) receptors: Binding, structure and molecular modelling
S Benyhe, F Zádor, F Ötvös
Acta Biologica Szegediensis 59 (suppl. 1.), 17-37, 2015
182015
Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors
F Zádor, F Ötvös, S Benyhe, A Zimmer, E Páldy
Neurochemistry international 61 (3), 378-388, 2012
182012
The peripheral versus central antinociception of a novel opioid agonist: acute inflammatory pain in rats
M Balogh, ZS Zádori, B Lázár, D Karádi, S László, SA Mousa, S Hosztafi, ...
Neurochemical research 43 (6), 1250-1257, 2018
152018
Inhibition of opioid receptor mediated G-protein activity after chronic administration of kynurenic acid and its derivative without direct binding to opioid receptors
F Zádor, R Samavati, E Szlávicz, B Tuka, E Bojnik, F Fulop, J Toldi, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
142014
Interactions between the kynurenine and the endocannabinoid system with special emphasis on migraine
G Nagy-Grócz, F Zádor, S Dvorácskó, Z Bohár, S Benyhe, C Tömböly, ...
International journal of molecular sciences 18 (8), 1617, 2017
132017
Opioid receptor activity and analgesic potency of DPDPE peptide analogues containing a xylene bridge
A Stefanucci, E Novellino, S Mirzaie, G Macedonio, S Pieretti, P Minosi, ...
ACS medicinal chemistry letters 8 (4), 449-454, 2017
122017
Further characterization of hemopressin peptide fragments in the opioid and cannabinoid systems
E Szlavicz, PS Perera, C Tomboly, Z Helyes, F Zador, S Benyhe, ...
Anesthesia & Analgesia 121 (6), 1488-1494, 2015
112015
Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamates
L Monti, A Stefanucci, S Pieretti, F Marzoli, L Fidanza, A Mollica, S Mirzaie, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 31 (6), 1638-1647, 2016
102016
Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine
L Kudla, R Bugno, U Skupio, L Wiktorowska, W Solecki, A Wojtas, ...
British Journal of Pharmacology 176 (23), 4434-4445, 2019
92019
Cyclic biphalin analogues incorporating a xylene bridge: synthesis, characterization, and biological profile
A Stefanucci, A Carotenuto, G Macedonio, E Novellino, S Pieretti, ...
ACS medicinal chemistry letters 8 (8), 858-863, 2017
82017
Preparation of bivalent agonists for targeting the mu opioid and cannabinoid receptors
S Dvorácskó, A Keresztes, A Mollica, A Stefanucci, G Macedonio, ...
European Journal of Medicinal Chemistry 178, 571-588, 2019
72019
New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology
F Zádor, K Király, A Váradi, M Balogh, Á Fehér, D Kocsis, AI Erdei, ...
European journal of pharmacology 809, 111-121, 2017
72017
Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum
R Samavati, F Zádor, E Szűcs, B Tuka, D Martos, G Veres, R Gáspár, ...
Journal of the Neurological Sciences 376, 63-70, 2017
72017
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20